Development of RNA interference-based therapy for rare genetic diseases
In December 2022, the Indonesian Ministry of Health projected that rare diseases might affect 8–10% of the population, equating to approximately 27 million people. These diseases, often congenital, are linked to genetic inheritance or mutations, leading to structural or functional defects. Despite...
Saved in:
| Main Authors: | Milya Urfa Ahmad, Syarifah Dewi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Indonesian Society for Biochemistry and Molecular Biology
2024-08-01
|
| Series: | Acta Biochimica Indonesiana |
| Subjects: | |
| Online Access: | https://pbbmi.org/newjurnal/index.php/actabioina/article/view/171 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1
by: Cristina Martin-Higueras, et al.
Published: (2024-01-01) -
Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial
by: Jeffrey M. Saland, et al.
Published: (2024-07-01) -
Acute Hepatic Porphyria – Minireview
by: Aida SAVU, et al.
Published: (2023-03-01) -
Real-Life Data of 2-Year Lumasiran Use in the DAILY-LUMA Cohort
by: Anne-Laure Sellier-Leclerc, et al.
Published: (2025-04-01) -
Acute hepatic porphyrias for the neurologist: current concepts and perspectives
by: Paulo Victor Sgobbi de Souza, et al.
Published: (2021-01-01)